for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Novavax starts late-stage COVID-19 vaccine trial in UK

Sept 24 (Reuters) - Novavax Inc on Thursday started a late-stage trial of its experimental COVID-19 vaccine in partnership with the UK government’s Vaccines Taskforce.

The trial is expected to enroll and test the vaccine on up to 10,000 individuals aged between 18 and 84 years over the next four to six weeks. (reut.rs/3j1Y4nV) (Reporting by Trisha Roy in Bengaluru; Editing by Aditya Soni)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up